Shaoyan Jiang

662 total citations
20 papers, 496 citations indexed

About

Shaoyan Jiang is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Shaoyan Jiang has authored 20 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Pharmacology. Recurrent topics in Shaoyan Jiang's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (6 papers). Shaoyan Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (6 papers). Shaoyan Jiang collaborates with scholars based in China and United States. Shaoyan Jiang's co-authors include Tao Yu, Yanyan Yang, Ningning Tang, Murugavel Ponnusamy, Shaoyan Liu, Hui Xin, Hong Chang, Yuanyuan Meng, Liang Zhao and Jianxun Wang and has published in prestigious journals such as Journal of Biological Chemistry, Atherosclerosis and BioMed Research International.

In The Last Decade

Shaoyan Jiang

19 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoyan Jiang China 13 335 225 66 54 48 20 496
Weihua Bian China 12 349 1.0× 195 0.9× 62 0.9× 85 1.6× 86 1.8× 27 523
Yanqing Zhou China 14 369 1.1× 214 1.0× 55 0.8× 20 0.4× 106 2.2× 41 645
Man Shang China 10 230 0.7× 103 0.5× 79 1.2× 34 0.6× 28 0.6× 20 371
Jingjing Gong China 13 240 0.7× 102 0.5× 55 0.8× 21 0.4× 36 0.8× 28 476
Aristeidis E. Boukouris Canada 8 331 1.0× 129 0.6× 41 0.6× 32 0.6× 32 0.7× 13 493
Shuo Liang China 12 333 1.0× 184 0.8× 65 1.0× 27 0.5× 87 1.8× 30 623
Zhenwei Ge China 7 360 1.1× 251 1.1× 44 0.7× 69 1.3× 38 0.8× 12 486

Countries citing papers authored by Shaoyan Jiang

Since Specialization
Citations

This map shows the geographic impact of Shaoyan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoyan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoyan Jiang more than expected).

Fields of papers citing papers by Shaoyan Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoyan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoyan Jiang. The network helps show where Shaoyan Jiang may publish in the future.

Co-authorship network of co-authors of Shaoyan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoyan Jiang. A scholar is included among the top collaborators of Shaoyan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoyan Jiang. Shaoyan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xi, Yu Huang, Xu Wang, et al.. (2023). Enhancing CO2 photoconversion activity of TiO2 via synergistic effects of La-doping and ammonia vapor heat treatment. Journal of Photochemistry and Photobiology A Chemistry. 441. 114755–114755. 9 indexed citations
3.
Li, Min, Yanyan Yang, Jinbao Zong, et al.. (2022). miR-564: A potential regulator of vascular smooth muscle cells and therapeutic target for aortic dissection. Journal of Molecular and Cellular Cardiology. 170. 100–114. 24 indexed citations
4.
He, Shan, et al.. (2022). IL-23 Inhibits Trophoblast Proliferation, Migration, and EMT via Activating p38 MAPK Signaling Pathway to Promote Recurrent Spontaneous Abortion. Journal of Microbiology and Biotechnology. 32(6). 792–799. 11 indexed citations
5.
Li, Xiaoxin, Yanyan Yang, Shaoyan Jiang, et al.. (2021). Targeting non-coding RNAs in unstable atherosclerotic plaques: Mechanism, regulation, possibilities, and limitations. International Journal of Biological Sciences. 17(13). 3413–3427. 39 indexed citations
6.
Zong, Tingyu, Yanyan Yang, Xiaotong Lin, et al.. (2021). 5′-tiRNA-Cys-GCA regulates VSMC proliferation and phenotypic transition by targeting STAT4 in aortic dissection. Molecular Therapy — Nucleic Acids. 26. 295–306. 42 indexed citations
7.
Fu, Xiuxiu, Xingqiang He, Yanyan Yang, et al.. (2021). Identification of transfer RNA-derived fragments and their potential roles in aortic dissection. Genomics. 113(5). 3039–3049. 27 indexed citations
8.
Liu, Shaoyan, Yanyan Yang, Shaoyan Jiang, et al.. (2019). MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1. Frontiers in Genetics. 10. 22–22. 44 indexed citations
9.
Jiang, Shaoyan, et al.. (2019). Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway. International Journal of Oncology. 54(6). 1933–1942. 34 indexed citations
10.
Jiang, Shaoyan, et al.. (2018). Renin-angiotensin system inhibitor attenuates oxidative stress induced human coronary artery endothelial cell dysfunction via the PI3K/AKT/mTOR pathway. Archives of Medical Science. 15(1). 152–164. 25 indexed citations
11.
Jiang, Shaoyan, et al.. (2018). [The Roles of Icariin on the Proliferation and Apoptosis Abilities of Human Oophoroma Cells and Multi-drug Resistant Cell Line].. PubMed. 49(4). 530–534. 3 indexed citations
12.
Liu, Shaoyan, Yanyan Yang, Shaoyan Jiang, et al.. (2018). Understanding the role of non-coding RNA (ncRNA) in stent restenosis. Atherosclerosis. 272. 153–161. 48 indexed citations
13.
Tang, Ningning, Shaoyan Jiang, Yanyan Yang, et al.. (2018). Noncoding RNAs as therapeutic targets in atherosclerosis with diabetes mellitus. Cardiovascular Therapeutics. 36(4). e12436–e12436. 55 indexed citations
14.
Jiang, Shaoyan, et al.. (2018). Research on Mission Pricing of Crowdsourcing APP. International Business Research. 11(4). 1–1.
15.
Jiang, Shaoyan, et al.. (2018). Icariin inhibits autophagy and promotes apoptosis in SKVCR cells through mTOR signal pathway. Cellular and Molecular Biology. 64(6). 4–10. 11 indexed citations
16.
Yang, Yanyan, Tao Yu, Shaoyan Jiang, et al.. (2017). miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204. Expert Opinion on Therapeutic Patents. 27(9). 1021–1029. 38 indexed citations
17.
Yu, Hua, Dan Li, Xian‐Ming Chu, et al.. (2014). Coronary heart disease: incidence, risk factors and interventions in Jiaozhou of Shandong province. Chinese Medical Journal. 127(12). 2275–2278. 5 indexed citations
18.
Chen, Gang, et al.. (2014). microRNA-802 promotes lung carcinoma proliferation by targeting the tumor suppressor menin. Molecular Medicine Reports. 10(3). 1537–1542. 20 indexed citations
19.
Li, Jian, et al.. (2014). Anti-CD133 Antibody Immobilized on the Surface of Stents Enhances Endothelialization. BioMed Research International. 2014. 1–9. 18 indexed citations
20.
Liu, Xijun, Dan Liu, Dongmeng Qian, et al.. (2012). Nucleophosmin (NPM1/B23) Interacts with Activating Transcription Factor 5 (ATF5) Protein and Promotes Proteasome- and Caspase-dependent ATF5 Degradation in Hepatocellular Carcinoma Cells. Journal of Biological Chemistry. 287(23). 19599–19609. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026